Laura Plantinga, PhD

Assistant Professor of Medicine

Emory Department of Medicine

Education

  • PhD, Epidemiology, Emory University
  • Master of Science, Biostatistics, Johns Hopkins University
  • Bachelor of Science, Zoology, University of Maryland

Biography

Dr. Plantinga’s research focuses on multidisciplinary approaches to improving the quality of care among patients with chronic diseases, including older patients and patients with chronic kidney disease (CKD), end-stage renal disease (ESRD), and lupus.

Dr. Plantinga currently leads studies funded by Satellite Healthcare (improving patient-centered care in dialysis via shared information on patient physical functioning; http://medicine.emory.edu/renal-medicine/renal-medicine-labs/informed/index.html) and AHRQ (identifying correlates of hospital readmissions in dialysis patients). She recently completed a pilot study of physical and cognitive functioning among lupus patients. Dr. Plantinga also collaborates on a variety of studies with Emory investigators in renal medicine, transplantation, geriatrics, rheumatology, hospital medicine, nursing, and epidemiology, as well as investigators outside of Emory, all aimed at improving care in underserved patient populations.

Dr. Plantinga is a Deputy Section Editor for BMC Nephrology and serves on the Editorial Board of Kidney International and the National Kidney Foundation’s Education Committee. She has been an author on >100 peer-reviewed manuscripts (http://www.ncbi.nlm.nih.gov/sites/myncbi/1hspgt-y-cfAm/bibliography/41092721/public/?sort=date&direction=descending).

Publications

For a more complete list of publications please view on PubMed.

Patzer RE, Gander J, Sauls L, Amamoo MA, Krisher J, Mulloy LL, Gibney E, Browne T, Plantinga L, Pastan SO. The RaDIANT community study protocol: community-based participatory research for reducing disparities in access to kidney transplantation. BMC Nephrol. 2014;15:171.

Plantinga LC, Drenkard C, Patzer RE, Klein M, Kramer MR, Pastan SO, Lim SS, McClellan WM. Sociodemographic and geographic predictors of quality of care in U.S. patients with end-stage renal disease due to lupus nephritis. Arthritis Rheumatol. 2014: in press.

Plantinga LC, Patzer RE, Drenkard C, Kramer MR, Klein M, Lim SS, McClellan WM, Pastan SO. Association of time to kidney transplantation with graft failure among U.S. patients with end-stage renal disease due to lupus nephritis. Arthritis Care Res. 2014: in press.

Patzer RE, Plantinga L, Krisher J, Pastan SO. Dialysis facility and network factors associated with low kidney transplantation rates among United States dialysis facilities. Am J Transplant. 2014;14:1562-1572.

Plantinga LC, Kim M, Goetz M, Kleinbaum DG, McClellan WM, Patzer RE. Pre-end-stage renal disease care not associated with dialysis facility neighborhood poverty in the United States. Am J Nephrol. 2014;39:50-58.

McClellan WM, Plantinga LC. A public health perspective on CKD and obesity. Nephrol Dialysis Transplant. 2013;28:iv37-iv42.

Plantinga L, Howard VJ, Judd S, Muntner P, Tanner R, Rizk D, Lackland DT, Warnock DG, Howard G, McClellan WM. Association of duration of residence in the southeastern United States with chronic kidney disease may differ by race: the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study. Int J Health Geogr. 2013;12:17. PMC3606831

Shahinian VB, Hedgeman E, Gillespie BW, Young EW, Robinson B, Hsu CY, Plantinga LC, Burrows NR, Eggers P, Saydah S, Powe NR, Saran R for the CDC CKD Surveillance System. Estimating prevalence of CKD stages 3-5 using health system data. Am J Kidney Dis. 2013;61:930-938.

Grubbs V, Plantinga LC, Tuot DS, Hedgeman E, Saran R, Saydah S, Rolka D, Powe N, for the CDC CKD Surveillance Team. Americans’ use of dietary supplements that are potentially harmful in chronic kidney disease. Am J Kidney Dis. 2013;61:739-747.

Tuot DS, Plantinga LC, Judd SE, Muntner P, Hsu C-Y, Warnock DG, Gutierrez OM, Safford M, Powe NR, McClellan WM. Healthy behaviors, risk factor control and awareness of chronic kidney disease. Am J Nephrol. 2013;37:135-143.

Plantinga L. Socio-economic impact in CKD [review]. Nephrol Ther. 2013;9:1-7. [in English]

Jaar BG, Chang A, Plantinga L. Can we improve quality of life of patients on dialysis?  [invited editorial]. Clin J Am Soc Nephrol. 2013;8:1-4.

Tuot DS, Plantinga LC, Hsu C-Y, Powe NR. Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes? Am J Nephrol. 2012:35:191-197. PMC3326277

Grubbs V, Plantinga LC, Vittinghoff E, O’Hare AM, Dudley RA. Medicare immunosuppressant coverage and access to kidney transplantation: a retrospective national cohort study. BMC Health Serv Res. 2012:12:254. PMC3470983

Grubbs V, Plantinga LC, Tuot DS, Powe NR. Chronic kidney disease and use of dental services in a United States public healthcare system: a retrospective cohort study. BMC Nephrol. 2012;13:16.

McClellan AC, Plantinga L, McClellan WM. Epidemiology, geography, and chronic kidney disease [review]. Curr Opin Nephrol Hypertens. 2012;21:323-328.

Plantinga LC, Tuot DS, Grubbs V, Hsu C-Y, Powe NR. Chronic kidney disease identification in a high-risk urban population: does automated eGFR reporting make a difference? J Urban Health. 2012;89:965-976.

Teaching